Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
Similar Publications
[Difficulties in surgical treatment of fixed cardiofundal axial esophageal hiatal hernia].
Khirurgiia (Mosk)
December 2024
Kuban State Medical University, Krasnodar, Russia.
One of the most common gastrointestinal diseases is esophageal hiatal hernia. It is the third most common disease after peptic ulcer and cholecystitis. We present surgical treatment of a patient with fixed axial cardiofundal hiatal hernia and previous laparoscopic repair of large hiatal hernia.
View Article and Find Full Text PDFMassive gastrointestinal hemorrhage and iodine-125 seed migration due to hepatogastric fistula: a case report and literature review.
Transl Cancer Res
November 2024
Mini-invasive Intervention Center, The Third Affiliated Hospital of the Naval Medical University, Shanghai, China.
Background: Hepatogastric fistula (HGF) is an uncommon occurrence that can be associated with various medical conditions. The primary causes typically involve peptic ulcer disease, infections (such as pyogenic, amoebic or tuberculosis), or iatrogenic factors (like post transarterial chemoembolization or radiotherapy). Massive gastrointestinal hemorrhage following HGF is extremely rare, with iodine-125 (I) seed migration to the stomach through HGF not previously documented.
View Article and Find Full Text PDFEpidemiology of asymptomatic peptic ulcer disease diagnosed during screening endoscopy in patients with cirrhosis.
J Int Med Res
December 2024
School of Public Health, Asrat Woldeyes Health Science Campus, Debre Berhan University, Debre Berhan, Ethiopia.
Objective: Asymptomatic peptic ulcer disease (PUD) is frequently overlooked in patients with cirrhosis, who are at increased risk for gastrointestinal complications that can lead to increased morbidity and mortality. We aimed to determine the prevalence and associated factors of asymptomatic PUD identified during screening endoscopy in patients with cirrhosis.
Methods: We conducted a retrospective cross-sectional study among patients with cirrhosis at St.
Medication use and risk of reflux oesophagitis.
BMJ Open Gastroenterol
December 2024
Department of Gastroenterology, National Center for Global Health and Medicine, Shinjuku-ku, Japan
Objective: Reflux oesophagitis (RO) is one of the most common diseases encountered by gastroenterologists and primary care physicians. However, few epidemiological studies have investigated the association of medication use and RO. This study aimed to investigate the prevalence of RO and its risk factors, particularly with respect to medication use.
View Article and Find Full Text PDFRole of high-dose amoxicillin dual therapy for eradication in an Irish cohort: A prospective study.
World J Clin Cases
December 2024
Interdisciplinary Department of Medicine, University of Bari "Aldo Moro", Bari 70124, Italy.
() infections may cause chronic gastritis, peptic ulcer disease, gastric cancers, and other conditions outside of the gastrointestinal tract. Hence, it is important to diagnose and treat it early. is resistant to certain drugs in traditional eradication therapy, so alternative therapy protocols are needed, such as high-dose amoxicillin dual therapy (HDADT).
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!